CLLS
Price
$3.18
Change
+$0.10 (+3.25%)
Updated
Sep 18, 12:12 PM (EDT)
Capitalization
319.82M
53 days until earnings call
SLN
Price
$5.01
Change
+$0.16 (+3.30%)
Updated
Sep 17 closing price
Capitalization
226.72M
61 days until earnings call
Interact to see
Advertisement

CLLS vs SLN

Header iconCLLS vs SLN Comparison
Open Charts CLLS vs SLNBanner chart's image
Cellectis SA
Price$3.18
Change+$0.10 (+3.25%)
Volume$100
Capitalization319.82M
Silence Therapeutics
Price$5.01
Change+$0.16 (+3.30%)
Volume$63.5K
Capitalization226.72M
CLLS vs SLN Comparison Chart in %
Loading...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLLS vs. SLN commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLLS is a Hold and SLN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (CLLS: $3.07 vs. SLN: $5.04)
Brand notoriety: CLLS and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLLS: 31% vs. SLN: 95%
Market capitalization -- CLLS: $319.82M vs. SLN: $226.72M
CLLS [@Biotechnology] is valued at $319.82M. SLN’s [@Biotechnology] market capitalization is $226.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLLS’s FA Score shows that 0 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • CLLS’s FA Score: 0 green, 5 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, CLLS is a better buy in the long-term than SLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 4 TA indicator(s) are bullish while SLN’s TA Score has 6 bullish TA indicator(s).

  • CLLS’s TA Score: 4 bullish, 4 bearish.
  • SLN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SLN is a better buy in the short-term than CLLS.

Price Growth

CLLS (@Biotechnology) experienced а +0.49% price change this week, while SLN (@Biotechnology) price change was +4.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +11.75%, and the average quarterly price growth was +38.63%.

Reported Earning Dates

CLLS is expected to report earnings on Nov 10, 2025.

SLN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLLS($320M) has a higher market cap than SLN($227M). CLLS YTD gains are higher at: 70.278 vs. SLN (-26.744). CLLS has higher annual earnings (EBITDA): -30.25M vs. SLN (-84.82M). CLLS has more cash in the bank: 196M vs. SLN (114M). SLN has less debt than CLLS: SLN (0) vs CLLS (94.8M). CLLS has higher revenues than SLN: CLLS (56.3M) vs SLN (27.2M).
CLLSSLNCLLS / SLN
Capitalization320M227M141%
EBITDA-30.25M-84.82M36%
Gain YTD70.278-26.744-263%
P/E RatioN/AN/A-
Revenue56.3M27.2M207%
Total Cash196M114M172%
Total Debt94.8M0-
FUNDAMENTALS RATINGS
CLLS: Fundamental Ratings
CLLS
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLLSSLN
RSI
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 1 day ago
88%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPKRF1.30N/A
N/A
Pepkor Holdings Ltd.
NACB65.00N/A
N/A
NATIONAL CAP BANCORP INC.
SDVKY27.36-0.13
-0.47%
Sandvik AB
RUPRF4.12-0.02
-0.48%
Rupert Resources Ltd.
CBSC0.04N/A
-5.00%
Cardiac Biotech Solutions Inc.

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been closely correlated with CMVLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLLS jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
-3.01%
CMVLF - CLLS
82%
Closely correlated
N/A
ABCZF - CLLS
58%
Loosely correlated
N/A
SLN - CLLS
43%
Loosely correlated
+3.92%
MDGL - CLLS
40%
Loosely correlated
-2.25%
PMVP - CLLS
38%
Loosely correlated
+4.17%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
+3.92%
CLLS - SLN
43%
Loosely correlated
-3.01%
CMVLF - SLN
38%
Loosely correlated
N/A
ABCZF - SLN
36%
Loosely correlated
N/A
ANNX - SLN
36%
Loosely correlated
-4.72%
NGNE - SLN
33%
Loosely correlated
+1.72%
More